OrthoPediatrics [KIDS] vs Conmed [CNMD] Detailed Stock Comparison
OrthoPediatrics
NASDAQ
Loading...
Conmed
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: OrthoPediatrics wins in 6 metrics, Conmed wins in 12 metrics, with 0 ties. Conmed appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | OrthoPediatrics | Conmed | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 246.27 | 15.44 | Conmed |
| Price-to-Book Ratio | 1.33 | 1.69 | OrthoPediatrics |
| Debt-to-Equity Ratio | 29.77 | 87.93 | OrthoPediatrics |
| PEG Ratio | -18.01 | 11.30 | OrthoPediatrics |
| EV/EBITDA | -38.43 | 11.54 | OrthoPediatrics |
| Profit Margin (TTM) | -18.92% | 8.31% | Conmed |
| Operating Margin (TTM) | -12.58% | 10.62% | Conmed |
| EBITDA Margin (TTM) | N/A | 10.62% | N/A |
| Return on Equity | -11.49% | 11.69% | Conmed |
| Return on Assets (TTM) | -4.38% | 4.03% | Conmed |
| Free Cash Flow (TTM) | $-41.31M | $153.88M | Conmed |
| Dividend Yield | N/A | 1.15% | N/A |
| 1-Year Return | -29.73% | -18.49% | Conmed |
| Price-to-Sales Ratio (TTM) | 2.15 | 1.28 | Conmed |
| Enterprise Value | $509.83M | $2.54B | Conmed |
| EV/Revenue Ratio | 2.31 | 1.92 | Conmed |
| Gross Profit Margin (TTM) | 72.07% | 55.01% | OrthoPediatrics |
| Revenue per Share (TTM) | $9 | $43 | Conmed |
| Earnings per Share (Diluted) | $-1.80 | $3.54 | Conmed |
| Beta (Stock Volatility) | 1.12 | 1.17 | OrthoPediatrics |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
OrthoPediatrics vs Conmed Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| OrthoPediatrics | -1.51% | -7.26% | -12.78% | -18.07% | -23.07% | -17.32% |
| Conmed | 2.42% | 4.55% | 4.23% | -5.33% | -18.79% | -18.83% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| OrthoPediatrics | -29.73% | -65.66% | -63.63% | 0.85% | 0.85% | 0.85% |
| Conmed | -18.49% | -47.00% | -35.80% | -2.50% | 178.36% | 88.32% |
Performance & Financial Health Analysis: OrthoPediatrics vs Conmed
| Metric | KIDS | CNMD |
|---|---|---|
| Market Information | ||
| Market Cap | $474.14M | $1.69B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 213,870 | 685,650 |
| 90 Day Avg. Volume | 170,243 | 550,407 |
| Last Close | $18.91 | $54.67 |
| 52 Week Range | $16.59 - $33.14 | $46.00 - $78.19 |
| % from 52W High | -42.94% | -30.08% |
| All-Time High | $73.91 (Nov 01, 2021) | $159.11 (Nov 01, 2021) |
| % from All-Time High | -74.41% | -65.64% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.16% | 0.03% |
| Quarterly Earnings Growth | 0.16% | -0.29% |
| Financial Health | ||
| Profit Margin (TTM) | -0.19% | 0.08% |
| Operating Margin (TTM) | -0.13% | 0.11% |
| Return on Equity (TTM) | -0.11% | 0.12% |
| Debt to Equity (MRQ) | 29.77 | 87.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $14.18 | $32.41 |
| Cash per Share (MRQ) | $2.80 | $1.10 |
| Operating Cash Flow (TTM) | $-28,884,000 | $165.21M |
| Levered Free Cash Flow (TTM) | $-17,784,500 | $163.74M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.15% |
| Last 12-Month Dividend | N/A | $0.60 |
Valuation & Enterprise Metrics Analysis: OrthoPediatrics vs Conmed
| Metric | KIDS | CNMD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 246.27 | 15.44 |
| Forward P/E | -18.01 | 11.30 |
| PEG Ratio | -18.01 | 11.30 |
| Price to Sales (TTM) | 2.15 | 1.28 |
| Price to Book (MRQ) | 1.33 | 1.69 |
| Market Capitalization | ||
| Market Capitalization | $474.14M | $1.69B |
| Enterprise Value | $509.83M | $2.54B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.31 | 1.92 |
| Enterprise to EBITDA | -38.43 | 11.54 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 1.17 |
| Book Value per Share (MRQ) | $14.18 | $32.41 |
Financial Statements Comparison: OrthoPediatrics vs Conmed
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KIDS | CNMD |
|---|---|---|
| Revenue/Sales | $52.41M | $321.26M |
| Cost of Goods Sold | $14.15M | $143.50M |
| Gross Profit | $38.26M | $177.75M |
| Research & Development | $2.35M | $12.95M |
| Operating Income (EBIT) | $-10.94M | $15.96M |
| EBITDA | $-4.25M | $34.21M |
| Pre-Tax Income | $-10.46M | $7.67M |
| Income Tax | $196,000 | $1.64M |
| Net Income (Profit) | $-10.66M | $6.04M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KIDS | CNMD |
|---|---|---|
| Cash & Equivalents | $33.44M | $35.49M |
| Total Current Assets | $232.06M | $639.00M |
| Total Current Liabilities | $37.51M | $283.15M |
| Long-Term Debt | $73.03M | $891.44M |
| Total Shareholders Equity | $347.15M | $977.64M |
| Retained Earnings | $-246.22M | $560.13M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KIDS | CNMD |
|---|---|---|
| Operating Cash Flow | $-1.11M | $49.72M |
| Capital Expenditures | $-4.23M | $-3.78M |
| Free Cash Flow | $-8.38M | $37.76M |
| Debt Repayment | $-126,000 | $-180.59M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KIDS | CNMD |
|---|---|---|
| Shares Short | 1.12M | 2.11M |
| Short Ratio | 8.93 | 4.86 |
| Short % of Float | 0.07% | 0.09% |
| Average Daily Volume (10 Day) | 213,870 | 685,650 |
| Average Daily Volume (90 Day) | 170,243 | 550,407 |
| Shares Outstanding | 24.22M | 30.90M |
| Float Shares | 16.78M | 30.68M |
| % Held by Insiders | 0.33% | 0.01% |
| % Held by Institutions | 0.71% | 1.15% |
Dividend Analysis & Yield Comparison: OrthoPediatrics vs Conmed
| Metric | KIDS | CNMD |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.60 |
| Last 12-Month Dividend Yield | N/A | 1.15% |
| 3-Year Avg Annual Dividend | N/A | $0.73 |
| 3-Year Avg Dividend Yield | N/A | 0.24% |
| 3-Year Total Dividends | N/A | $2.20 |
| Ex-Dividend Date | N/A | Mar 14, 2025 |